These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 31852546)
1. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon. Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546 [TBL] [Abstract][Full Text] [Related]
2. Availability, prices and affordability of selected essential medicines in Jordan: a national survey. Alefan Q; Amairi R; Tawalbeh S BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486 [TBL] [Abstract][Full Text] [Related]
3. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557 [TBL] [Abstract][Full Text] [Related]
4. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. Ewen M; Zweekhorst M; Regeer B; Laing R PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413 [TBL] [Abstract][Full Text] [Related]
5. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China. Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology. Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276 [TBL] [Abstract][Full Text] [Related]
7. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937 [TBL] [Abstract][Full Text] [Related]
8. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria. Orubu ESF; Robert FO; Samuel M; Megbule D Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074 [TBL] [Abstract][Full Text] [Related]
9. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348 [TBL] [Abstract][Full Text] [Related]
10. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India. Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria. Osuafor NG; Ukwe CV; Okonta M PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799 [TBL] [Abstract][Full Text] [Related]
12. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012 [TBL] [Abstract][Full Text] [Related]
13. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China. Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137 [TBL] [Abstract][Full Text] [Related]
14. Availability, prices and affordability of essential medicines in Zhejiang Province, China. Dong Z; Tao Q; Yan B; Sun G PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336 [TBL] [Abstract][Full Text] [Related]
15. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam. Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554 [TBL] [Abstract][Full Text] [Related]
16. Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology. Kasonde L; Tordrup D; Naheed A; Zeng W; Ahmed S; Babar ZU BMC Health Serv Res; 2019 Jun; 19(1):383. PubMed ID: 31196078 [TBL] [Abstract][Full Text] [Related]
17. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico. Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676 [TBL] [Abstract][Full Text] [Related]
18. Prices, Availability and Affordability of Medicines with Value-Added Tax Exemption: A Cross-Sectional Survey in the Philippines. Lambojon K; Chang J; Saeed A; Hayat K; Li P; Jiang M; Atif N; Desalegn GK; Khan FU; Fang Y Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708060 [TBL] [Abstract][Full Text] [Related]
19. Prices, availability and affordability of medicines in Rwanda. Bizimana T; Kayumba PC; Heide L PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100 [TBL] [Abstract][Full Text] [Related]
20. Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis. Wang H; Sun Q; Vitry A; Nguyen TA Asia Pac J Public Health; 2017 May; 29(4):268-277. PubMed ID: 28397532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]